Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Present and future anxiolytics

M Briley, C Moret

    Idrugs : the Investigational Drugs Journal
    |August 5, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The von Willebrand factor/ADAMTS13 ratio as an indicator of venous thromboembolism risk: results from the RETROVE project.

    Journal of thrombosis and thrombolysis·2025
    Same author

    Under-correction of preoperative varus alignment does not lead to a difference in in-vivo bone loading in 3D-SPECT/CT compared to neutral alignment.

    The Knee·2022
    Same author

    Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders.

    Human genomics·2016
    Same author

    The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Effects of scopolamine treatment and lesion of the nucleus basalis upon various cholinergic markers in the rat brain cortex.

    Neurochemistry international·2010
    Same author

    In vivo [(3)H]ketanserin binding: effect of modifying synaptic serotonin levels.

    Neurochemistry international·2010
    Same journal

    Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.

    IDrugs : the investigational drugs journal·2010
    Same journal

    Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.

    IDrugs : the investigational drugs journal·2010
    Same journal

    LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

    IDrugs : the investigational drugs journal·2010
    Same journal

    Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

    IDrugs : the investigational drugs journal·2010
    Same journal

    Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.

    IDrugs : the investigational drugs journal·2010
    Same journal

    Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

    IDrugs : the investigational drugs journal·2010
    See all related articles